SF Healthcare Week: Vera Therapeutics’ announced this week that the FDA accepted the company’s filing for atacicept, a potential new treatment for IgA Nephropathy
BiotechTV - News
00:00
GFR Endpoint and Accelerated Approval Pathway
Marshall discusses GFR as a confirmatory endpoint and accelerated approval based on reduced proteinuria.
Play episode from 04:02
Transcript
